Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of stock option activities

v3.22.1
Shareholders' Deficit (Details) - Schedule of stock option activities - Stock options [Member]
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]  
Number of Options, Balance Outstanding, Beginning (in Shares) | shares 8,445,698
Weighted Average Exercise Price, Balance Outstanding, Beginning (in Dollars per share) | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 4 months 24 days
Aggregate Intrinsic Value, Balance Outstanding, Ending | $ $ 0
Number of Options, Exercised (in Shares) | shares
Weighted Average Exercise Price, Exercised (in Dollars per share) | $ / shares
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Options, Balance Outstanding, Ending (in Shares) | shares 8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending (in Dollars per share) | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending | $ $ 4,200,000
Number of Options, Exercisable (in Shares) | shares 8,445,698
Weighted Average Exercise Price, Exercisable (in Dollars per share) | $ / shares $ 0.4
Weighted Average Remaining Contractual Term (Years), Exercisable, 4 years 2 months 12 days
Aggregate Intrinsic Value, Exercisable | $ $ 0